TRPM7 kinase is required for insulin production and compensatory islet responses during obesity

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Diseases

Background:

• Overweight individuals often maintain glucose homeostasis via compensatory islet responses.
• Identifying pathways that enhance beta cell compensation is crucial for diabetes treatment.
• Transient Receptor Potential Cation Channel Subfamily M Member 7 (TRPM7) is a protein with kinase activity involved in cell growth.

Purpose of the Study:

• To investigate the role of TRPM7 in beta cell function and glucose homeostasis.
• To determine the impact of TRPM7 deletion or impaired kinase activity on insulin secretion and glucose tolerance.

Main Methods:

• Selective deletion of Trpm7 in mouse beta cells.
• Assessment of insulin secretion and glucose tolerance in Trpm7-knockout mice.
• Analysis of Trpm7 kinase activity in high-fat-fed mice.
• Evaluation of AKT/ERK signaling pathways.

Main Results:

• Beta cell-specific Trpm7 deletion disrupted insulin secretion and caused glucose intolerance.
• Impaired TRPM7 kinase activity led to decreased insulin production and hyperglycemia in high-fat-fed mice.
• Reduced compensatory beta cell responses were linked to mitigated AKT/ERK signaling.

Conclusions:

• TRPM7 kinase plays a critical role in regulating insulin synthesis and beta cell function.
• TRPM7 is a novel regulator of glucose homeostasis, particularly under obesogenic conditions.
• Targeting TRPM7 kinase may offer a new therapeutic strategy for managing diabetes.